Created at Source Raw Value Validated value
Nov. 26, 2021, 10:30 p.m. oms

One of the following COVID-19 specific; inpatient; postoperative pulmonary complications: Pneumonia; Acute respiratory distress syndrome; Death <br/ >Timepoint: All randomised participants will be followed up until death; discharge from hospital; or 30 days post-randomisation (whichever is sooner). Longer-term follow-up (e.g. 5 years) will be sought as appropriate to each participating countryâ??s settings.

One of the following COVID-19 specific; inpatient; postoperative pulmonary complications: Pneumonia; Acute respiratory distress syndrome; Death <br/ >Timepoint: All randomised participants will be followed up until death; discharge from hospital; or 30 days post-randomisation (whichever is sooner). Longer-term follow-up (e.g. 5 years) will be sought as appropriate to each participating countryâ??s settings.

Nov. 13, 2021, 5:33 p.m. oms

N/A

N/A

Oct. 26, 2020, 8:29 a.m. oms

One of the following COVID-19 specific; inpatient; postoperative pulmonary complications: Pneumonia; Acute respiratory distress syndrome; Death <br/ >Timepoint: All randomised participants will be followed up until death; discharge from hospital; or 30 days post-randomisation (whichever is sooner). Longer-term follow-up (e.g. 5 years) will be sought as appropriate to each participating countryâ??s settings.

One of the following COVID-19 specific; inpatient; postoperative pulmonary complications: Pneumonia; Acute respiratory distress syndrome; Death <br/ >Timepoint: All randomised participants will be followed up until death; discharge from hospital; or 30 days post-randomisation (whichever is sooner). Longer-term follow-up (e.g. 5 years) will be sought as appropriate to each participating countryâ??s settings.